30.01.2023 - NEW YORK, Jan. 30, 2023 (GLOBE NEWSWIRE) - Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Patrick Fabbio as . Seite 1